OLIPOP

1.1 Identity and business model

OLIPOP sells a soda positioned around digestive-health benefits from its proprietary OLISMART fiber and botanical blend. The official storefront currently separates the portfolio into a refrigerated 9 g fiber line and a shelf-stable 6 g fiber line, indicating a packaged-goods model designed for both cold-chain and ambient retail placement rather than a software-like recurring-revenue model. Oakland is consistently identified as the headquarters. The founding date is less settled: CompWorth and Tracxn use 2017, while Wikipedia uses 2018. That one-year discrepancy is not material to product-market fit, but it should be normalized before legal or financing documents rely on a canonical incorporation or operating-start date.[CO001, CO002, CO003, CO004, CO005]

1.2 Founder leadership and governance visibility

Publicly visible leadership remains concentrated in co-founders Ben Goodwin and David Lester. Goodwin is identified as CEO and formulator in the 2026 campaign announcement, while Lester is consistently identified as co-founder. This pairing supplies unusually direct founder-product fit: product formulation, category narrative, and executive authority remain closely linked. It also creates key-person exposure because the assigned evidence does not provide a reliable current executive roster, board committee structure, ownership schedule, or succession plan. Tracxn publishes a board list, but duplicated founder names and limited role context make it insufficient as a definitive governance record.[CO001, CO006]

1.3 Capital history and scale signals

The best-corroborated financing marker is a $50 million Series C announced in February 2025 at a reported $1.85 billion valuation. Cumulative funding is not reconciled: Tracxn reports $243 million over five rounds, whereas FundedIQ reports $80 million over two disclosed rounds. Those totals likely reflect different round inclusion and normalization rules, so neither should be treated as cash available. Scale estimates are similarly non-comparable. Public sources mix company revenue, retailer GMV and employee bands; the most defensible reading is that OLIPOP has substantial national distribution, while audited company-wide revenue, current headcount, gross margin, cash and operating cash flow remain unavailable.[CO011, CO013, CO014, CO015, CO016]

1.4 Milestones and diligence read-through

The milestone sequence shows a rapid progression from seed financing through national brand scale, shelf-stable product development and a 2026 national creative refresh. Historical setbacks also matter: the founders' predecessor beverage, Obi, was sold after failing to gain traction, illustrating that the current outcome followed an earlier unsuccessful concept rather than a frictionless launch. The 2026 campaign and packaging refresh demonstrate continued brand investment, but the assigned adverse search returned no retained source on lawsuits or regulatory proceedings. That is an evidence gap, not proof of a clean record; current docket, claims-substantiation and regulatory checks remain necessary before an investment decision.[CO007, CO008, CO009, CO010, CO012]

1.5 Exhibits

2.1 Market boundary and substitutes

The investable market should be bounded more narrowly than all non-alcoholic beverages. OLIPOP's core offer is soda with a proprietary fiber and botanical blend, sold in refrigerated 9 g-fiber and shelf-stable 6 g-fiber lines. That places the company directly in functional and prebiotic soda, while adjacent spend includes lower-sugar soda, sparkling water, kombucha, and other functional drinks. Conventional full-sugar and diet soda are the principal status-quo substitutes because the product deliberately uses familiar soda formats and flavors. Alcoholic drinks, supplements, and unrelated wellness products are excluded from the core market even when they compete for a broader health-and-wellness budget. This boundary prevents a broad beverage headline from being mistaken for OLIPOP's realistically addressable demand.[CM001, CM002, CM004, CM010]

2.2 Evidence-constrained sizing

The assigned sources do not provide a transparent, absolute dollar estimate for U.S. prebiotic soda, so an investment-grade TAM/SAM/SOM cannot be stated. Mosaic instead reports relative demand signals: an OLIPOP demand index of 50, latest growth of -28.6%, 6.5% share of search, and a 43.8% growth signal for its much broader soft-drinks category. Mosaic explicitly says these values are indexed or relative and that no absolute search volumes are displayed. Distribution supplies a separate reach lens: Wikipedia reports availability through more than 65,000 U.S. retailers. These measures are directionally useful but are not mutually convertible; search interest is not revenue, category growth is not company growth, and store count is not sell-through.[CM003, CM006, CM007, CM008, CM009, CM010]

2.3 Buyer, payer, and adoption path

The end consumer is both user and payer in direct-to-consumer purchases, while retailers act as channel gatekeepers and category-budget owners for shelf access, promotion, and replenishment. Assigned third-party material emphasizes health-conscious younger consumers, traditional-soda switchers, and shoppers seeking flavor without conventional sugar levels. Adoption therefore depends on a sequence: awareness and trial, taste acceptance, repeat purchase, and reliable retail availability. OLIPOP's shelf-stable line broadens placement beyond refrigerated cases, while its reported national retail footprint lowers access friction. The evidence does not disclose account-level velocity, repeat-purchase cohorts, retailer concentration, or trade-spend economics, so distribution breadth cannot be treated as proof of durable consumer pull.[CM002, CM003, CM011, CM012, CM014]

2.4 Drivers, constraints, and valuation relevance

Flavor, nostalgia, lower sugar, functional positioning, and expanded retail availability are the clearest adoption drivers in the assigned evidence. Accio reports that 61% of functional-beverage drinkers prioritize flavor quality, although its underlying survey method is not disclosed. OLIPOP's 2026 national campaign and packaging refresh reinforce the familiar-soda framing rather than relying only on health claims. Constraints are material: one low-reputation analysis flags a roughly $2.50-per-can premium, Mosaic's latest demand signal is negative, and a secondary source reports a class action challenging digestive-health marketing. The legal report lacks a primary court record in this pool. Valuation should therefore reward verified repeat demand and velocity, not category narratives or distribution alone.[CM005, CM007, CM011, CM013, CM015, CM016]

2.5 Exhibits

3.1 Landscape and Peer Scale

The buyer can satisfy the same refreshment or wellness job through direct prebiotic sodas, probiotic or synbiotic drinks, zero-sugar soda, incumbent-backed launches, sparkling water, or a do-it-yourself fiber drink. Latterly's comparison names Poppi, Culture Pop, Health-Ade Pop, Wildwonder, Zevia, and several sparkling-water or fermented-beverage alternatives, while Tracxn identifies Culture Pop as a funded direct peer. Scale evidence is uneven: Wikipedia reports OLIPOP in more than 65,000 retailers, MetricsCart reports PepsiCo acquired Poppi for $1.95 billion in May 2025, and Tracxn reports $43.7 million of funding for Culture Pop. Comparable funding, revenue, door-count, and share data are unavailable for most alternatives, so the profile table preserves those fields as unknown rather than implying equal scale.[CP010, CP012, CP013, CP016]

3.2 Product Capability and Trust

The assigned comparisons consistently distinguish OLIPOP through fiber rather than through an exclusive consumption occasion. OLIPOP's current official surface presents a refrigerated 9 g fiber line and a shelf-stable 6 g line; SugarMinder and HealthRx compare the core 9 g offer with Poppi at 2 g and Zevia at 0 g. Other rivals change the mechanism instead of matching that dose: Culture Pop emphasizes live probiotics, Wildwonder combines prebiotics and probiotics, and Zevia removes sugar and calories without a fiber payload. This supports a formulation distinction, not a clinical or regulatory moat. The pool contains no primary legal record, controlled head-to-head product test, retailer scorecard, or independent substantiation of brand health claims. The matrix therefore labels unsupported trust, compliance, and sensory cells as unknown.[CP001, CP002, CP003, CP011]

3.3 Pricing, Packaging, and Channel Power

Public price observations are channel-specific rather than realized net pricing. HealthRx reports single-can bands of roughly $2.49-$2.99 for OLIPOP and $1.99-$2.49 for Poppi, whereas SugarMinder reports $2.50-$3.50 for OLIPOP, $2.50-$3.00 for Poppi, and $1.00-$1.50 for Zevia; neither comparison establishes a common retailer and date. MetricsCart measures a different denominator—average Amazon listing price across mixed products and pack sizes—and reports $15.03 for OLIPOP against $19.60 for Poppi during July 13-26, 2026. On that same observed digital shelf, both brands averaged 4.4 stars, but Poppi had about 380,000 reviews versus 220,000 for OLIPOP and launched eight new listings versus one. Those signals favor Poppi's online visibility, while MetricsCart still concluded that neither brand held a clear overall Amazon advantage.[CP004, CP005, CP006, CP007, CP008, CP009]

3.4 Switching Cost and Moat Durability

OLIPOP's disclosed fiber dose and two-line packaging architecture create a legible shelf proposition, but the evidence does not establish contractual lock-in or a proprietary route to the consumer. HealthRx describes a do-it-yourself sparkling-water and fiber alternative at roughly $0.40-$0.60 per serving and says bulk inulin is seven to sixteen times cheaper per gram of fiber than OLIPOP. At the branded end, PepsiCo ownership gives Poppi potential distribution and marketing leverage, yet MetricsCart also reports Poppi's US retail volume down 3.6% and dollar sales down 3.3% in the first half of 2026. The resulting moat is best characterized as brand, formulation, and execution dependent: consumers can multi-home among taste, sugar, fiber, price, and convenience propositions, while retailer access and repeat purchase remain unmeasured.[CP010, CP011, CP014, CP015]

3.5 Exhibits

4.1 Revenue Model, Pricing Architecture, and Channel Dynamics

OLIPOP operates an omni-channel consumer packaged goods model driven primarily by wholesale grocery, mass retail, and club distribution, supplemented by direct-to-consumer online sales. The core product portfolio comprises prebiotic soft drinks formulated across two primary architectures: the original refrigerated 9g prebiotic fiber line and a shelf-stable 6g fiber line. In wholesale channels, OLIPOP distributes through more than 50,000 retail storefronts nationwide, spanning grocery leaders like Kroger and Publix, natural grocers like Whole Foods, and mass retailers including Target, Walmart, and Costco. List pricing in retail typically ranges from $2.49 to $2.99 per single 12 oz can, while direct-to-consumer purchases on drinkolipop.com are sold via 12-can variety or single-flavor packs. While digital commerce represents a valuable testing and retention channel, third-party analytics indicate that drinkolipop.com generated roughly $12 million in GMV in 2025, confirming that physical retail wholesale accounts for more than 95% of total company gross turnover.[CI001, CI002, CI003, CI004]

4.2 Cost Structure, Channel Economics, and Unit Economics Proxies

The brand's cost structure reflects the operational realities of scaling high-growth functional beverages through national cold-chain and ambient distribution networks. Primary cost of goods sold components include functional ingredients (notably the proprietary OLISMART blend of prebiotic fibers, botanicals, and fruit juices), aluminum beverage cans, contract co-packing fees, and multi-node freight. Operating expenses are heavily weighted toward retailer trade spend (including slotting allowances, promotional discounts, and endcap placement fees), national performance marketing, and creator partnerships. OLIPOP differentiated its GTM efficiency by maintaining exceptionally high retail sales velocity before door expansion, achieving over $200 million in annual run-rate with only 28,000 retail locations—substantially fewer doors than traditional CPG benchmarks require. Furthermore, social creator campaigns achieved an impression cost of approximately $0.61 per thousand impressions (CPM), providing top-of-funnel consumer pull that reduced reliance on conventional above-the-line television advertising.[CI005, CI006, CI007, CI008]

4.3 Public Traction, Capital Adequacy, and dilgence Underwriting Verdict

OLIPOP demonstrated rapid commercial acceleration, growing gross turnover from under $1 million at launch in 2019 to $8.6 million in 2020, $29.7 million in 2021, $73.4 million in 2022, $200 million in 2023, and surpassing $400 million in 2024, with public management guidance projecting roughly $500 million for 2025. Crucially, leadership confirmed that the business attained operating profitability in early 2024, mitigating the chronic cash burn typical of venture-backed beverage startups. Capital adequacy was further solidified in February 2025 with a $50 million Series C funding round led by J.P. Morgan Private Capital's Growth Equity Partners, valuing the enterprise at $1.85 billion post-money and bringing cumulative equity capital raised to roughly $243 million. Total corporate headcount stands at approximately 195 to 373 remote employees across operations, field sales, and marketing. From an underwriting standpoint, OLIPOP represents an institutional-grade growth asset with strong organic cash generation; however, definitive financial verification is constrained by private company disclosure opacity—specifically the absence of audited financial statements, unquantified trade spend deductions, and the contingent liability of pending consumer class action litigation regarding fiber efficacy.[CI009, CI010, CI011, CI012, CI013, CI014]

4.4 Exhibits

5.1 Product and Format Architecture

OLIPOP is delivered as a consumer packaged beverage rather than a software product: the customer job is to substitute a familiar soda occasion with a product marketed as lower in sugar and higher in fiber. The current official surface presents two operating formats, an original refrigerated 9g-fiber line and a shelf-stable 6g-fiber line. That split is strategically important because it changes where the product can be stored and merchandised, while also changing the fiber formulation and quantity. Secondary reporting says the shelf-stable formula replaces two inulin inputs with acacia and guar fibers and carries roughly 30% less fiber, so the two lines should not be treated as nutritionally identical.[CE001, CE002, CE004]

5.2 Quality and Release Controls

The strongest technical evidence concerns process governance rather than a proprietary manufacturing breakthrough. OLIPOP says approved ingredient suppliers must maintain preventive controls, good manufacturing practices, traceability, recall readiness, and proper storage and handling. It also says every production facility is GFSI-certified and externally audited, while formulas and processes receive review from an FDA-recognized third-party authority. Finished batches are described as undergoing accredited third-party laboratory testing that includes heavy-metal screening. These are meaningful control layers, but they remain company-issued descriptions: the assigned evidence does not disclose audit reports, laboratory results, facility identities, failure rates, recall simulations, or supplier concentration.[CE005, CE006, CE007, CE008]

5.3 Deployment, Commerce, and Roadmap Signals

Deployment occurs through both retail formats and direct-to-consumer commerce. The 2026 packaging refresh was concentrated on the shelf-stable 6g line, with the refrigerated 9g line left unchanged, indicating that ambient distribution is the current presentation and merchandising focus. A designer portfolio describes work on OLIPOP's mobile funnel, product-detail pages, checkout, and subscription dashboard and claims large conversion and subscription-rate gains; those figures are useful practitioner evidence but are not an independent benchmark or an audited company disclosure. Product leadership also changed in 2026, with reporting that founder Ben Goodwin moved toward innovation while Christian Patiño Webb assumed the CEO role, creating a clearer split between product development and operating scale.[CE003, CE009, CE010, CE011, CE014]

5.4 Differentiation and Diligence Limits

Publicly visible differentiation is a bundle of formulation, format flexibility, quality-control claims, brand design, and channel execution rather than a demonstrated patent or software moat. A branding consultancy's retrospective says OLIPOP devoted most of its initial capital to branding, consistent with the importance of packaging and nostalgia to the proposition, but that historical spending figure is not independently corroborated here. The company also extended the brand into gummies and lip balm in 2026, suggesting that consumer recognition can travel beyond beverages; the evidence does not establish durable cross-category economics. Most importantly, this source pool contains no peer-reviewed human efficacy study, technical patent record, named co-manufacturer map, or independently verified digital performance dataset.[CE012, CE013, CE015]

5.5 Exhibits

6.1 Customer Segmentation and Demographic Profile

OLIPOP's primary consumer demographic consists of health-curious millennials and Gen Z soda drinkers seeking lower-sugar alternatives to traditional soft drinks [CU001, CU002]. The brand repositioned from its early clinical framing as a digestive tonic toward a mainstream lifestyle soda, expanding its consumer reach across demographic segments [CU003, CU004]. Customer demand flows through two primary buyer segments: mass-market grocery and mass-retail shoppers purchasing individual refrigerated cans, and direct-to-consumer subscribers purchasing recurring 12-can variety bundles online [CU005, CU006]. While brand marketing emphasizes digestive wellbeing and fiber content, consumers primarily purchase based on nostalgic flavor profiles such as vintage cola, root beer, and fruit blends rather than clinical indications [CU001, CU007]. Wholesale retail accounts serve as the payer for nationwide physical shelf inventory, whereas end consumers act as users and retail purchasers [CU008].

6.2 Adoption Trajectory and Channel Proof

Adoption trajectory reflects rapid distribution scaling from 40 Northern California grocery doors at founding in 2018 to more than 65,000 retail storefronts nationwide by 2026 [CU008, CU009]. The company achieved $73.4 million in gross revenue in 2022, growing to an estimated $400 million in 2024 as retail shelf velocity accelerated in grocery accounts such as Target and Walmart [CU005, CU008, CU010]. In 2021, the company curtailed traditional paid social ads and shifted capital toward affiliate creator networks and influencer gifting [CU005, CU011]. Partnering with over 1,900 creators through partnership platforms, creator promotions accounted for roughly 12% of total company sales in 2024, demonstrating that social proof directly supports omnichannel customer acquisition [CU011, CU012]. Marketplace presence on platforms such as Amazon provides an additional trial mechanism that captures search intent and drives subsequent retail discovery [CU005, CU013].[CU005, CU008, CU009, CU010, CU011, CU012, CU013]

6.3 Retention Durability, Expansion Loops, and Channel Concentration

Customer retention relies heavily on recurring DTC subscriptions, seasonal limited-edition flavor collaborations, and packaging format extensions [CU005, CU006, CU007]. To improve customer adoption and retail penetration across non-refrigerated retail shelves, OLIPOP launched a 6-gram fiber shelf-stable product line alongside its original refrigerated 9-gram formulation [CU014, CU015]. Strategic licensing collaborations with cultural franchises including Barbie and SpongeBob create temporary purchase spikes and attract trial users outside standard wellness circles [CU004, CU008]. However, customer retention is vulnerable to skepticism regarding gut health marketing claims and pending class-action litigation challenging fiber-based digestive health statements [CU008, CU016]. Furthermore, retail distribution remains heavily concentrated in top accounts such as Target, Walmart, and regional grocery chains, leaving OLIPOP vulnerable to distributor margin pressure and slotting fee dynamics [CU008].

6.4 Exhibits

7.1 Regulatory Scrutiny and Health Claim Advertising Litigation

OLIPOP operates in the highly scrutinized functional beverage category where brand positioning and premium retail price points ($2.49 to $3.29 per single can) depend heavily on marketed digestive health benefits. In December 2025, plaintiffs filed Somers v. Olipop, Inc. in the U.S. District Court for the Eastern District of New York alleging deceptive marketing, consumer fraud, and false advertising regarding prebiotic gut-health claims and fiber efficacy. While docket records confirm that Jordan Somers filed a notice of voluntary dismissal without prejudice on April 8, 2026, leading to an electronic dismissal order by Judge Ramon E. Reyes, Jr. on April 9, 2026, the underlying exposure persists. Third-party legal monitoring through August 2026 demonstrates ongoing class action vulnerability, where competitor precedents such as Poppi's $8.9 million prebiotic soda settlement underscore the substantial financial exposure and mandatory labeling modification risks if claims are refiled or targeted by regulatory bodies like the FTC or FDA.[CR001, CR002, CR003, CR004, CR005]

7.2 Formulation Bifurcation, Cold-Chain Dependencies, and Quality Assurance

Operational execution at OLIPOP requires managing dual manufacturing and supply chain architectures following the introduction of its shelf-stable product line. The original refrigerated 9g fiber line relies on cold-chain logistics and chicory root and Jerusalem artichoke inulin. In contrast, the shelf-stable 6g fiber line reformulates the proprietary OLISMART blend using acacia fiber and guar fiber, resulting in an approximate 30% reduction in total fiber per can. In June 2026, OLIPOP launched its updated visual identity and refreshed packaging specifically for the 6g line while keeping the refrigerated 9g line unchanged. This formulation split creates distinct operational failure modes, including consumer confusion over varying fiber dosages, increased co-manufacturing quality assurance complexity, cold-chain distribution disruptions for refrigerated inventory, and vulnerability to agricultural input price volatility for specialized botanical and prebiotic soluble fiber ingredients.[CR006, CR007, CR008, CR009]

7.3 Retail Partner Concentration, Corporate Scaling, and Valuation Governance

OLIPOP has expanded its physical retail presence to over 65,000 retail storefronts nationwide, including major national footprint partners such as Target and Walmart. However, heavy reliance on mass retail and grocery brokers exposes the business to slotting fee inflation, category reset risks, inventory chargebacks, and potential retail buyer pushback. Corporate filings and venture databases record corporate incorporation on December 10, 2017, with 195 tracked corporate employees as of March 31, 2025, alongside broader industry estimates citing approximately 373 total remote team members by August 2025. Following a Series C capitalization round led by J.P. Morgan Private Capital valuing the entity at $1.85 billion on $50 million raised, the company must sustain profitable operations while navigating remote workforce coordination, brand equity dilution from non-beverage merchandising extensions, and market expectations set by its late-stage private valuation.[CR010, CR011, CR012, CR013, CR014]

7.4 Exhibits

8.1 Investment Thesis and Anti-Thesis

The core investment thesis for OLIPOP centers on its demonstrated leadership in the functional soft drink category, converting mainstream consumer beverage demand toward low-sugar and high-fiber digestive wellness alternatives. The company crossed $400 million in sales for 2024, doubling revenue from 2023, while achieving operating profitability in early 2024 and securing national retail placement across more than 50,000 stores. Category dynamics indicate that roughly half of its brand growth is captured directly from legacy soda consumers seeking healthier formulations without compromising on taste, while the remainder attracts new drinkers into carbonated soft drinks. Furthermore, secondary transaction prints tracked by market observers in mid-2026 reached $2.1 billion, reflecting sustained private investor appetite for scaled consumer product platforms. Conversely, the anti-thesis highlights substantial legal, regulatory, and multiple risks that cap near-term risk-adjusted returns. In the Eastern District of New York, OLIPOP faces the Somers v. Olipop, Inc. consumer class action alleging that its gut health marketing claims are deceptive because excessive inulin fiber can cause gastrointestinal discomfort and the beverage contains added sugars. Compounding this legal exposure, category competitor Poppi entered settlement discussions over similar health-claim litigation, demonstrating systemic vulnerability across prebiotic soda branding. In response to functional stability challenges and market feedback, OLIPOP revised its proprietary OLISMART formulation for its shelf-stable line, substituting acacia and guar fiber for chicory root and reducing fiber content by approximately 30%. With public beverage incumbents trading at forward multiples of 2.5x to 4.5x revenue, OLIPOP's private round multiple of 4.6x 2024 sales leaves minimal margin of safety if litigation alters labeling or consumer velocity slows. [CV001, CV002, CV003, CV004, CV005, CV006, CV007, CV008]

8.2 Capitalization History and Valuation Context

OLIPOP's capital trajectory reflects rapid expansion from a regional Northern California brand into a nationally distributed enterprise valued at $1.85 billion. Seed funding in 2019 of $2.5 million was followed by an October 2021 Series B round of $39.8 million at a $200 million post-money valuation, led by Monogram Capital Partners alongside prominent celebrity backers. In February 2025, the company closed its Series C round, securing $50 million led by J.P. Morgan Private Capital's Growth Equity Partners at a $1.85 billion post-money mark. Cumulative disclosed funding reached between $95 million and $243 million depending on whether secondary share sales and growth equity tranches are aggregated, with commercial databases confirming an active institutional cap table including Raptor Group and Fifth Down Capital. From a valuation discipline perspective, the $1.85 billion post-money Series C represents a trailing revenue multiple of approximately 4.6x on 2024 sales exceeding $400 million. This multiple represents a significant premium relative to mature public beverage conglomerates such as Coca-Cola (approx. 5.5x EV/Sales) and Keurig Dr Pepper (approx. 3.2x EV/Sales), yet remains defensible for a category disruptor expanding retail footprint past 65,000 doors while generating positive operating income. Private secondary prints observed in mid-2026 around $2.1 billion demonstrate constructive private liquidity, though lack of an active S-1 filing indicates management is preserving strategic optionality between an initial public offering and a trade sale to beverage conglomerates. [CV001, CV002, CV003, CV004, CV009, CV010, CV011, CV012]

8.3 Scenario Analysis, Exit Pathways, and Diligence Roadmap

A three-scenario financial and exit framework establishes an intrinsic valuation range spanning $1.20 billion to $3.00 billion across base, bull, and bear cases. In the Base Case ($2.00 billion valuation, 50% probability), OLIPOP delivers high-teens retail volume growth, manages the Somers litigation through a modest structured settlement without damaging core trademark equity, successfully expands its 6g shelf-stable line, and executes an IPO or strategic sale at 3.5x to 4.0x forward sales. In the Bull Case ($3.00 billion valuation, 25% probability), international market expansion into Canada, Asia, and Australia accelerates top-line growth past $700 million, multi-category brand extensions such as gummy supplements and lip balms capture incremental wallet share, and an acquirer pays a strategic premium exceeding 5.0x sales. Under the Bear Case ($1.20 billion valuation, 25% probability), adverse judicial or regulatory rulings in the Somers litigation mandate severe labeling revisions that curtail consumer willingness to pay, competitor price discounting erodes gross margins, and growth slows below 10%, causing exit multiples to compress to 2.0x sales. Key diligence priorities prior to direct capital commitment include obtaining audited FY2024–FY2025 financial statements (specifically gross margins and operating cash flow), reviewing court records and proposed settlement terms in Somers v. Olipop, Inc., evaluating retailer-level scan data for volume repeat rates, and auditing co-packing master service agreements for unit manufacturing cost stability. [CV005, CV006, CV007, CV008, CV013, CV014, CV015, CV016]

8.4 Exhibits